Dividend investment
Search documents
Why Lockheed Martin Corporation (LMT) is Considered a Safe Haven for Dividend Investors
Yahoo Finance· 2025-09-29 17:33
Group 1 - Lockheed Martin Corporation (LMT) is recognized as one of the 10 Best Recession Proof Dividend Stocks to Buy, highlighting its resilience in economic downturns [1] - The company operates primarily in the defense and aerospace sectors, with significant contracts from the federal government, including projects like the F-35 combat aircraft and missile defense systems [2][3] - Lockheed Martin benefits from a strong backlog of contracts due to its established reputation and partnerships with the US government, ensuring revenue visibility for the future [3] Group 2 - Despite fluctuations in defense spending, Lockheed Martin maintains steady profits through a diverse portfolio and a solid baseline of funding, making it largely independent of broader economic cycles [4] - The company has a strong dividend history, having increased its payouts for 22 consecutive years, with a current quarterly dividend of $3.30 per share and a dividend yield of 2.71% as of September 26 [4]
Why the Schwab U.S. Dividend Equity ETF Could Be a Top Choice for Dividend Investors in 2025
The Motley Fool· 2025-09-28 18:09
Group 1 - The article emphasizes the advantages of investing in dividend exchange-traded funds (ETFs) over individual dividend stocks, highlighting the benefits of regular payouts and diversification [1] - The Schwab U.S. Dividend Equity ETF (SCHD) is identified as a top choice for income investors in 2025, particularly due to its strong performance and low expense ratio [2][4] - The SCHD ETF tracks the Dow Jones U.S. Dividend 100 Index, focusing on stocks with a history of consistent dividend payouts and superior fundamentals [3] Group 2 - The SCHD ETF has a low expense ratio of 0.06%, translating to $6 in annual fees per $10,000 invested, and manages total net assets of $71 billion [4] - The top holdings of the SCHD ETF include companies from dividend-friendly sectors such as healthcare, energy, consumer cyclical, and industrial [5] - The SCHD ETF offers one of the highest dividend yields compared to other funds in its class, making it appealing for income-focused investors [7][9] Group 3 - While the SCHD ETF provides consistent payouts, the actual distribution amounts may vary due to different dividend schedules of the underlying companies [5] - The article notes a limited exposure to the technology sector within the SCHD ETF, which may be a concern for investors looking to capitalize on tech trends [10] - Investors are advised to consider adding a tech ETF or top-performing tech stocks to their portfolio for exposure to major trends like artificial intelligence, alongside the SCHD ETF [11]
Capital City Bank (CCBG) is a Top Dividend Stock Right Now: Should You Buy?
ZACKS· 2025-09-26 16:46
Core Insights - The primary focus for income investors is generating consistent cash flow from liquid investments, which can come from dividends, bond interest, and other investment interests [1][2] Company Overview - Capital City Bank (CCBG), headquartered in Tallahassee, has experienced a price change of 15.99% this year and currently pays a dividend of $0.26 per share, resulting in a dividend yield of 2.45% [3] - The company's dividend yield surpasses the Banks - Southeast industry's yield of 2.29% and the S&P 500's yield of 1.54% [3] Dividend Growth - CCBG's current annualized dividend of $1.04 reflects an 18.2% increase from the previous year [4] - Over the past five years, the company has raised its dividend five times, averaging an annual increase of 12.29% [4] - The future growth of dividends will depend on earnings growth and the payout ratio, which is currently at 28% [4] Earnings Expectations - The Zacks Consensus Estimate for CCBG's earnings in 2025 is projected at $3.43 per share, indicating a year-over-year growth rate of 9.94% [5] Investment Considerations - CCBG is viewed as an attractive dividend investment and a compelling opportunity, holding a Zacks Rank of 2 (Buy) [6]
Prediction: Buying High-Yield Schwab U.S. Dividend Equity ETF Today Could Set You Up for Life
The Motley Fool· 2025-09-26 08:55
Core Viewpoint - Schwab U.S. Dividend Equity ETF offers an attractive yield of 3.6%, significantly higher than the average yield of 1.2% for S&P 500 stocks, making it a compelling option for long-term dividend investors [2][9] Group 1: ETF Overview - Schwab U.S. Dividend Equity ETF is an index-tracking ETF that follows the Dow Jones U.S. Dividend 100 Index, which was specifically created for this ETF [3] - The index excludes stocks with fewer than 10 consecutive annual dividend increases and real estate investment trusts (REITs), focusing on financially strong companies [5] - Stocks are scored based on cash flow to total debt, return on equity, dividend yield, and five-year dividend growth rate, ensuring a selection of companies with growth potential and a history of dividend increases [6][8] Group 2: Investment Features - The ETF provides a balanced combination of yield and capital growth, making it suitable for investors seeking reliable income without the need for extensive stock selection [9][10] - With a modest expense ratio of 0.06%, the ETF is cost-effective for investors [8] - Schwab U.S. Dividend Equity ETF can serve as a foundational investment for dividend investors and can be paired with bond ETFs or other dividend-focused ETFs for a diversified portfolio [10][11] Group 3: Long-term Income Potential - The ETF's unique approach to selecting dividend stocks positions it to deliver a reliable income stream for investors over the long term, allowing for tailored investment strategies [11]
3 Top Dividend ETFs to Hold for 10 Years
247Wallst· 2025-09-23 15:13
Core Insights - The article discusses dividend exchange-traded funds (ETFs) that offer high yields and potential for capital appreciation, suggesting they may outperform the market over the next decade [1] Group 1: High Yield and Upside Potential - Dividend ETFs are highlighted for their ability to provide attractive yields, which can be appealing to income-focused investors [1] - The potential for capital appreciation in these funds is emphasized, indicating that they may offer both income and growth opportunities [1] Group 2: Market Performance Outlook - The article suggests that these dividend ETFs could outperform the broader market over the next 10 years, making them a strategic investment choice [1]
2 of the Best Bank Stocks Investors Can Buy Today
The Motley Fool· 2025-09-23 08:55
Core Investment Thesis - Canadian banks, specifically Toronto-Dominion Bank (TD) and Bank of Nova Scotia (Scotiabank), offer higher dividend yields compared to average large U.S. banks, with TD at 3.9% and Scotiabank at 4.9% [1][2] Group 1: Regulatory Environment - Canadian banking regulations are stricter than those in the U.S., leading to a more stable and conservative banking environment [3][6] - TD and Scotiabank benefit from entrenched industry positions due to regulatory support, creating an oligopolistic market structure [5] Group 2: Historical Performance - Both banks have maintained consistent dividend payments for over 100 years, demonstrating reliability and resilience during economic downturns [6][7] - Unlike U.S. banks, TD and Scotiabank did not cut dividends during the 2007-2009 recession, showcasing their conservative management approach [6] Group 3: Growth Prospects - TD Bank's U.S. division faced challenges due to regulatory issues related to money laundering, resulting in an asset cap that limits growth until resolved [8][10] - Scotiabank is shifting focus from Central and South America to increase its presence in the U.S. market, including a nearly 15% stake in KeyCorp [11][12] Group 4: Investment Appeal - Both banks are positioned as attractive options for dividend investors, with Scotiabank showing aggressive growth strategies and recent dividend increases as a sign of positive transition [13] - Despite recent price gains, TD and Scotiabank have lower forward-looking P/E ratios compared to U.S. banks like Citigroup, indicating potential undervaluation and growth opportunities [15]
Prediction: Chevron Will Help Make You Richer by 2030
The Motley Fool· 2025-09-21 22:25
Core Viewpoint - Investing in Chevron is a strategic decision for long-term wealth accumulation, particularly for dividend investors, despite the volatility in the energy sector [1][5]. Group 1: Investment Rationale - The energy sector, particularly oil and natural gas, is characterized by high volatility, which can significantly impact companies like Chevron [2]. - Despite the volatility, the global dependence on oil and natural gas ensures robust demand, making energy companies essential [4]. - Chevron currently offers an attractive dividend yield of 4.3%, which is significantly higher than the broader market's 1.2% and the average energy stock's 3.2% [6]. Group 2: Financial Strength - Chevron has a strong balance sheet with a low debt-to-equity ratio of 0.2x, allowing it to manage downturns effectively and support its dividend payments [10]. - The company has a history of increasing its dividend for 38 consecutive years, showcasing its reliability as a dividend-paying stock [6]. Group 3: Long-term Outlook - Chevron's diversified business model across upstream, midstream, and downstream operations helps mitigate the inherent swings in the energy cycle [7][8]. - Investing in Chevron can provide a hedge against rising energy prices, as its stock is likely to appreciate during such times, contributing to long-term wealth growth [12].
How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock
Yahoo Finance· 2025-09-21 12:01
Core Viewpoint - Bristol-Myers Squibb Co. is expected to report a decline in Q3 2025 earnings, with analysts projecting an EPS of $1.67 and quarterly revenue of $11.76 billion, indicating a decrease from the previous year [2] Financial Performance - The company reported Q2 2025 earnings with an adjusted EPS of $1.46, which was below the consensus estimate of $1.58, while revenues of $12.30 billion exceeded the consensus of $11.31 billion [3] - Bristol-Myers Squibb's dividend yield stands at 5.37%, with a total dividend payout of $2.48 per share over the last 12 months [2] Future Guidance - The company has raised its full-year 2025 revenue guidance from approximately $45.8 billion to $46.8 billion to a new range of $46.5 billion to $47.5 billion [4] - CEO Christopher Boerner emphasized the focus on advancing transformational medicines and optimizing the company's cost structure to support long-term growth [4]
Got $5,000? This Dividend ETF Could Be a No-Brainer Buy
Yahoo Finance· 2025-09-20 12:45
Core Viewpoint - Investing in the stock market with a focus on generating recurring dividend income while also having the potential for long-term value appreciation is a strategic approach for utilizing available funds effectively [1]. Group 1: Investment Options - Exchange-traded funds (ETFs) provide a balanced investment across many stocks, reducing the need to monitor individual stock performance [2]. - The Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) is highlighted as a strong option for dividend investors due to its diversification and focus on safe dividend stocks [3][8]. Group 2: Dividend Yield and Comparison - The Schwab U.S. Dividend Equity ETF offers a high dividend yield of 3.7%, significantly higher than the S&P 500's average yield of 1.2% [5]. - A $5,000 investment in the Schwab ETF could yield approximately $185 in dividends annually, compared to only $60 from an S&P 500 ETF [6]. Group 3: Fund Characteristics - The Schwab U.S. Dividend Equity ETF invests in around 100 stocks, minimizing risk by not relying on a few high-yielding stocks [6]. - The fund tracks the Dow Jones U.S. Dividend 100 index, focusing on quality and sustainability of dividends rather than just high yields [9]. - Notable holdings in the Schwab ETF include blue-chip companies like Verizon Communications, PepsiCo, and Chevron, which are recognized for their reliable and growing dividend payouts [9].
This 12% Dividend Is on Sale as a $30 Bn ’Hidden’ Move Sparks Buying Opportunity
Investing· 2025-09-18 09:47
Group 1 - Eli Lilly and Company is highlighted for its strong performance in the pharmaceutical sector, particularly in diabetes and obesity treatments [1] - Vertex Pharmaceuticals Inc is noted for its advancements in cystic fibrosis therapies, which continue to drive revenue growth [1] - Amgen Inc is recognized for its robust pipeline and focus on innovative therapies, contributing to its competitive position in the biotech industry [1] Group 2 - The abrdn Healthcare Opportunities Fund is discussed as a strategic investment vehicle focusing on healthcare sector opportunities, aiming to capitalize on market trends [1]